Young People's Experience of ADHD and Stimulant Medication: A Qualitative Study for the NICE Guideline

Child and Adolescent Mental Health

Volumn 15, Issue 4, 2010, Pages 186-192

  Singh, Ilina ^a   Kendall, Tim ^b   Taylor, Clare ^b   Mears, Alex ^c   Hollis, Chris ^d   Batty, Martin ^d   Keenan, Sinead ^a  

^a LONDON SCHOOL OF ECONOMICS   (United Kingdom)

^b ROYAL COLLEGE OF PSYCHIATRISTS   (United Kingdom)

^c Healthcare Commission   (United Kingdom)

^d UNIVERSITY OF NOTTINGHAM   (United Kingdom)

Author keywords

ADHD; Attention Deficit Hyperactivity Disorder; Methylphenidate; Stimulants

Indexed keywords

CENTRAL STIMULANT AGENT;

ADOLESCENT; ARTICLE; ATTENTION DEFICIT DISORDER; CHILD; CLINICAL ARTICLE; EVIDENCE BASED PRACTICE; FEMALE; HUMAN; INFORMATION PROCESSING; INTERVIEW; MALE; MEDICAL RESEARCH; PEER GROUP; PERSONAL EXPERIENCE; PRACTICE GUIDELINE; PRIORITY JOURNAL; QUALITATIVE RESEARCH; SCHOOL CHILD; STIGMA; UNITED KINGDOM;

EID: 77958586176     PISSN: 1475357X     EISSN: 14753588     Source Type: Journal    
DOI: 10.1111/j.1475-3588.2010.00565.x     Document Type: Article

References (18)

1. Boseley, S. (2008). Doctors urged to stop use of Ritalin for under-fives. The Guardian, 24 September.
2. Clout, L. (2008). Parents warned over the dangers of Ritalin. Daily Express, 24 September.
3. Conrad, P. (2006). Identifying hyperactive children: The medicalization of deviant behavior. London: Ashgate.
4. DuPaul, G., & Barkley, R.A. (1990). Medication therapy. In R.A. Barkley (Ed.), Attention-deficit hyperactivity disorder: A handbook for diagnosis and treatment. New York: Guilford Press.
5. Kendall, J., Hatton, D., Beckett, A., & Leo, M. (2003). Children's accounts of attention-deficit/hyperactivity disorder. ANS Advances in Nursing Science, 26, 114-130.
6. Kutcher, S., Aman, M., Brooks, S.J., Buitelaar, J., Van Daalen, E., Fegert, J., Findling, R.L., Fisman, S., Greenhill, L.L., Huss, M., Kusumakar, V., Pine, D., Taylor, E., & Tyano, S. (2004). International consensus statement on attention- deficit/hyperactivity disorder (ADHD) and disruptive behaviour disorders (DBDs): Clinical implications and treatment practice suggestions. European Neuropsychopharmacol, 14, 11-28.
7. Laurance, J. (2008). Ritalin over-prescribed to children. The Independent, 24 September.
8. MacRae, F. (2008). Use Ritalin with caution, says NICE. Daily Mail, 24 September.
9. McNeal, R.E., Roberts, M.C., & Barone, V.J. (2000). Mothers' and children's perceptions of medication for children with attention-deficit hyperactivity disorder. Child Psychiatry and Human Development, 30, 173-187.
10. Meaux, J., Hester, C., Smith, B., & Shoptaw, A. (2006). Stimulant medications: A trade-off? The lived experience of adolescents with ADHD. Journal for Specialists in Pediatric Nursing, 11, 214-226.
11. Miles, M., & Huberman, A. (1984). Qualitative data analysis. London: Sage.
12. NICE (2008). Attention deficit hyperactivity disorder: Diagnosis and management of ADHD in children, young people and adults. NICE Clinical Guideline 72. London: NICE.
13. Olfson, M., Gameroff, M.J., Marcus, S.C., & Jensen, P.S. (2003). National trends in the treatment of attention deficit hyperactivity disorder. American Journal of Psychiatry, 160, 1071-1077.
14. Pope, C., Ziebland, S., & Mays, N. (2000). Qualitative research in health care: Analysing qualitative data. British Medical Journal, 320, 114-116.
15. President's Council on Bioethics (2003). Beyond therapy: Biotechnology and the pursuit of happiness. Washington, DC: James Bennett Pty, Ltd.
16. Ritchie, J., & Spencer, L. (1993). Qualitative data analysis for applied policy research. In A. Bryman & R. Burgess (Eds.) Analysing qualitative data. London: Routledge.
17. Singh, I. (2007a). Clinical implications of ethical concepts: Moral self-understandings in children taking methylphenidate for ADHD. Clinical Child Psychology and Psychiatry, 12, 167-182.
18. Singh, I. (2007b). Capacity and competence in children as research participants. EMBO Reports, 8, 35-39.